A tumor metastasis‐associated molecule <scp>TWIST1</scp> is a favorable target for cancer immunotherapy due to its immunogenicity-Reference-Cited by-同舟云学术

A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity

Published:2022-05-27 Issue:8 Volume:113 Page:2526-2535
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Yajima Yuki¹,Kosaka Akemi²,Ishibashi Kei³,Yasuda Shunsuke³,Komatsuda Hiroki²^ORCID,Nagato Toshihiro²,Oikawa Kensuke²,Kitada Masahiro³,Takekawa Masanori¹,Kumai Takumi⁴^ORCID,Ohara Kenzo⁴,Ohkuri Takayuki²^ORCID,Kobayashi Hiroya²

Affiliation:

1. Department of Oral and Maxillofacial Surgery Asahikawa Medical University Asahikawa Hokkaido Japan

2. Department of Pathology Asahikawa Medical University Asahikawa Hokkaido Japan

3. Breast Center Asahikawa Medical University Asahikawa Hokkaido Japan

4. Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Hokkaido Japan

Funder

Japan Agency for Medical Research and Development

Asahikawa Medical University

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15429

Reference35 articles.

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

2. Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines

3. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

4. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

5. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer;Medicine;2024-04-12

2. Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena;Cell Biochemistry and Function;2024-03-29

3. How does TCR-T cell therapy exhibit a superior anti-tumor efficacy;Biochemical and Biophysical Research Communications;2023-12

4. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity;Heliyon;2023-09

5. Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review;Vaccines;2023-03-13